In this study, using the FISH technique, we analyzed the copy number alterations of HER2, MDM2, c-MYC, c-MET, and TP53 in CTC obtained from GC patients to evaluate their application as a potential alternative to tumor biopsy. This evidence concerns the gene ERBB2 and gastric cancer.